RecruitingNot ApplicableNCT07247136

Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System

Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)


Sponsor

Neuspera Medical, Inc.

Enrollment

30 participants

Start Date

Nov 19, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Single-arm study conducted in participants for the treatment of urinary urge incontinence in patients who have failed, could not tolerate, or were not a candidate for more conservative treatments. The objective of the study is to assess the effectiveness of 30-minutes daily therapeutic stimulation with the Neuspera System.


Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Neuspera Implantable Sacral Neuromodulation System for people with urinary urge incontinence. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENeuspera Implantable Sacral Neuromodulation System

Stimulation of the Sacral Nerve


Locations(1)

Southern Urogynecology, LLC

West Columbia, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07247136


Related Trials